Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss partial oral treatment of left-sided infectious endocarditis (POET); early vs. deferred invasive ACS examination and treatment (VERDICT); pre-treatment with P2Y12 receptor antagonists not associated with improved UA/NSTEMI clinical outcomes (SCAAR); and a mendelian randomized study examining effects of triglyceride-rich lipoproteins on CV risk.

Keywords: ESC18, ESC Congress

< Back to Listings